Department of Commerce

The National Institute of Standards and Technology (NIST), a part of the US Department of Commerce, proposed a slate of detrimental changes to regulations in the Bayh-Dole Act governing “Rights to Federally Funded Inventions and Licensing of Government Owned Invention.” The public was given the opportunity to comment on the proposed changes, and by the close of the comment period on April 5, 2021 NIST had received over 81,000 comments on the issue. The proposed changes cover a variety of areas that impact policies concerning access to medicines and drug pricing, including patients’ rights to challenge the government’s grant of a taxpayer-funded invention to aRead More →